|
BCKDHB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.1160000024677E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.20279999585804E-08 |
| Normal-vs-Stage2 |
1.844360E-04 |
| Normal-vs-Stage3 |
1.003430E-03 |
| Normal-vs-Stage4 |
3.84079999999898E-05 |
| Stage1-vs-Stage2 |
9.274000E-01 |
| Stage1-vs-Stage3 |
8.602400E-01 |
| Stage1-vs-Stage4 |
5.667200E-01 |
| Stage2-vs-Stage3 |
8.430600E-01 |
| Stage2-vs-Stage4 |
4.809400E-01 |
| Stage3-vs-Stage4 |
6.218600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.19499999790196E-08 |
| Normal-vs-AfricanAmerican |
1.75430000004528E-06 |
| Normal-vs-Asian |
6.815700E-03 |
| Caucasian-vs-AfricanAmerican |
8.894600E-01 |
| Caucasian-vs-Asian |
8.746800E-01 |
| AfricanAmerican-vs-Asian |
8.274400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.81019998569366E-09 |
| Normal-vs-Female |
1.565360E-04 |
| Male-vs-Female |
1.468590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.07709999994799E-07 |
| Normal-vs-Extreme_Weight |
5.37920041843165E-10 |
| Normal-vs-Obese |
4.04969999999727E-05 |
| Normal-vs-Extreme_Obese |
1.751010E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.278400E-01 |
| Normal_Weight-vs-Obese |
3.069000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.444200E-01 |
| Extreme_Weight-vs-Obese |
8.618300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.290790E-01 |
| Obese-vs-Extreme_Obese |
6.176600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.89178999999706E-05 |
| Normal-vs-Age(41-60Yrs) |
9.31770000045518E-08 |
| Normal-vs-Age(61-80Yrs) |
5.50420000022811E-07 |
| Normal-vs-Age(81-100Yrs) |
3.67629999999952E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.186600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.672800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.957800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.813400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.994200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.612400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.37289999766222E-08 |
| Normal-VS-Type2 PRCC |
3.970500E-04 |
| Normal-VS-KIRP CIMP |
2.724000E-03 |
| Normal-VS-Unclassified PRCC |
1.61780999999861E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.292400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.616200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.406600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.447800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.126600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.600800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.9792000000306E-07 |
| Normal-vs-N1 |
4.400600E-04 |
| Normal-vs-N2 |
5.8616999999983E-05 |
| N0-vs-N1 |
6.250200E-01 |
| N0-vs-N2 |
2.500600E-01 |
| N1-vs-N2 |
1.641970E-01 |
|
|
